BSEM
Price
$12.45
Change
+$0.20 (+1.63%)
Updated
Jul 10 closing price
Capitalization
204.49M
46 days until earnings call
CLVLY
Price
$6.42
Change
-$0.42 (-6.14%)
Updated
Jul 10 closing price
Capitalization
345.63M
Interact to see
Advertisement

BSEM vs CLVLY

Header iconBSEM vs CLVLY Comparison
Open Charts BSEM vs CLVLYBanner chart's image
BioStem Technologies
Price$12.45
Change+$0.20 (+1.63%)
Volume$41.38K
Capitalization204.49M
Clinuvel Pharmaceuticals
Price$6.42
Change-$0.42 (-6.14%)
Volume$21.26K
Capitalization345.63M
BSEM vs CLVLY Comparison Chart in %
Loading...
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLVLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSEM vs. CLVLY commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSEM is a Hold and CLVLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (BSEM: $12.45 vs. CLVLY: $6.42)
Brand notoriety: BSEM and CLVLY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BSEM: 78% vs. CLVLY: 1331%
Market capitalization -- BSEM: $204.49M vs. CLVLY: $345.63M
BSEM [@Biotechnology] is valued at $204.49M. CLVLY’s [@Biotechnology] market capitalization is $345.63M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSEM’s FA Score shows that 0 FA rating(s) are green whileCLVLY’s FA Score has 1 green FA rating(s).

  • BSEM’s FA Score: 0 green, 5 red.
  • CLVLY’s FA Score: 1 green, 4 red.
According to our system of comparison, CLVLY is a better buy in the long-term than BSEM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSEM’s TA Score shows that 3 TA indicator(s) are bullish while CLVLY’s TA Score has 3 bullish TA indicator(s).

  • BSEM’s TA Score: 3 bullish, 6 bearish.
  • CLVLY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CLVLY is a better buy in the short-term than BSEM.

Price Growth

BSEM (@Biotechnology) experienced а +4.27% price change this week, while CLVLY (@Biotechnology) price change was -8.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

BSEM is expected to report earnings on Aug 26, 2025.

CLVLY is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLVLY($346M) has a higher market cap than BSEM($204M). CLVLY has higher P/E ratio than BSEM: CLVLY (12.85) vs BSEM (8.47). BSEM YTD gains are higher at: -10.043 vs. CLVLY (-16.623). CLVLY has higher annual earnings (EBITDA): 63.4M vs. BSEM (-8.62M). CLVLY has higher revenues than BSEM: CLVLY (91.6M) vs BSEM (6.04M).
BSEMCLVLYBSEM / CLVLY
Capitalization204M346M59%
EBITDA-8.62M63.4M-14%
Gain YTD-10.043-16.62360%
P/E Ratio8.4712.8566%
Revenue6.04M91.6M7%
Total Cash110KN/A-
Total Debt6.02MN/A-
FUNDAMENTALS RATINGS
BSEM vs CLVLY: Fundamental Ratings
BSEM
CLVLY
OUTLOOK RATING
1..100
603
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
56100
SMR RATING
1..100
10045
PRICE GROWTH RATING
1..100
5961
P/E GROWTH RATING
1..100
6596
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLVLY's Valuation (3) in the null industry is somewhat better than the same rating for BSEM (56). This means that CLVLY’s stock grew somewhat faster than BSEM’s over the last 12 months.

BSEM's Profit vs Risk Rating (56) in the null industry is somewhat better than the same rating for CLVLY (100). This means that BSEM’s stock grew somewhat faster than CLVLY’s over the last 12 months.

CLVLY's SMR Rating (45) in the null industry is somewhat better than the same rating for BSEM (100). This means that CLVLY’s stock grew somewhat faster than BSEM’s over the last 12 months.

BSEM's Price Growth Rating (59) in the null industry is in the same range as CLVLY (61). This means that BSEM’s stock grew similarly to CLVLY’s over the last 12 months.

BSEM's P/E Growth Rating (65) in the null industry is in the same range as CLVLY (96). This means that BSEM’s stock grew similarly to CLVLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSEMCLVLY
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
56%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
76%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
59%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BSEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLVLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRIDX73.24N/A
N/A
T. Rowe Price International Discovery
GEMOX13.37N/A
N/A
Goldman Sachs Emerging Mkt Eq ex. ChnInv
IIRSX12.48N/A
N/A
Voya Russell Small Cap Index Port I
EKBDX14.64N/A
N/A
Allspring Diversified Cap Bldr Adm
IVNQX47.09N/A
N/A
Invesco Nasdaq 100 Index R6

BSEM and

Correlation & Price change

A.I.dvisor tells us that BSEM and VTYX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSEM and VTYX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSEM
1D Price
Change %
BSEM100%
+1.63%
VTYX - BSEM
22%
Poorly correlated
+18.33%
ABSI - BSEM
20%
Poorly correlated
-3.53%
AURA - BSEM
20%
Poorly correlated
+2.73%
CELU - BSEM
20%
Poorly correlated
+1.89%
CLVLY - BSEM
11%
Poorly correlated
-6.14%
More

CLVLY and

Correlation & Price change

A.I.dvisor tells us that CLVLY and ADAP have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLVLY and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLVLY
1D Price
Change %
CLVLY100%
-6.14%
ADAP - CLVLY
22%
Poorly correlated
-0.54%
QLGN - CLVLY
21%
Poorly correlated
+0.03%
ATNM - CLVLY
20%
Poorly correlated
-1.90%
BSEM - CLVLY
11%
Poorly correlated
+1.63%
CMXHF - CLVLY
10%
Poorly correlated
-0.14%
More